Encompass Health Co. (NYSE:EHC) Stake Decreased by TD Asset Management Inc.

TD Asset Management Inc. lowered its position in Encompass Health Co. (NYSE:EHC - Free Report) by 10.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,522,909 shares of the company's stock after selling 171,467 shares during the period. TD Asset Management Inc. owned approximately 1.51% of Encompass Health worth $140,641,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB raised its position in Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock worth $27,000 after acquiring an additional 137 shares during the last quarter. Avior Wealth Management LLC purchased a new position in shares of Encompass Health during the 3rd quarter worth approximately $40,000. CBIZ Investment Advisory Services LLC raised its position in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after purchasing an additional 127 shares during the last quarter. Tompkins Financial Corp purchased a new stake in Encompass Health in the 4th quarter valued at approximately $46,000. Finally, V Square Quantitative Management LLC grew its holdings in Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after buying an additional 177 shares during the last quarter. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Trading Down 0.4 %

EHC stock traded down $0.39 during trading on Friday, reaching $100.75. 457,600 shares of the stock traded hands, compared to its average volume of 649,885. Encompass Health Co. has a 52-week low of $78.53 and a 52-week high of $104.55. The firm has a market capitalization of $10.15 billion, a PE ratio of 22.59, a P/E/G ratio of 2.31 and a beta of 0.92. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The business's 50 day moving average price is $98.67 and its 200-day moving average price is $97.42.

Remove Ads

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. As a group, sell-side analysts forecast that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.67%. Encompass Health's dividend payout ratio (DPR) is presently 15.25%.

Insider Buying and Selling

In other news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. This trade represents a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.10% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on EHC shares. William Blair restated an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. StockNews.com raised shares of Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. Barclays raised their target price on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a research report on Friday, February 7th. Royal Bank of Canada reiterated an "outperform" rating and issued a $110.00 price target on shares of Encompass Health in a report on Tuesday, February 11th. Finally, KeyCorp raised their price objective on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Ten equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $107.67.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.